Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Williamson

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
NPJ Precision Oncology|August 9, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancersJoan Miguel Romero, Emma Titmuss, Yifan Wang, et al.
Cold Spring Harbor Molecular Case Studies|June 5, 2019
Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumorLaura M Williamson, Michael Steel, Jasleen K Grewal, et al.
NPJ Precision Oncology|March 25, 2023
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy durationErica S Tsang, Veronika Csizmok, Laura M Williamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic CancerJoanna M Karasinska, James T Topham, Steve E Kalloger, et al.
NPJ Precision Oncology|December 21, 2021
Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyuryLaura M Williamson, Craig M Rive, Daniela Di Francesco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2020
Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid TumorsAlexandra Pender, Emma Titmuss, Erin D Pleasance, et al.
Molecular Cancer Therapeutics|June 11, 2020
Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer TypesJames T Topham, Emma Titmuss, Erin D Pleasance, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic CancersErica S Tsang, Cameron J Grisdale, Erin Pleasance, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular CharacteristicsJames T Topham, Joanna M Karasinska, Michael K C Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?Erica S Tsang, James T Topham, Joanna M Karasinska, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
NPJ Precision Oncology|August 9, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancersJoan Miguel Romero, Emma Titmuss, Yifan Wang, et al.
Cold Spring Harbor Molecular Case Studies|June 5, 2019
Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumorLaura M Williamson, Michael Steel, Jasleen K Grewal, et al.
NPJ Precision Oncology|March 25, 2023
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy durationErica S Tsang, Veronika Csizmok, Laura M Williamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic CancerJoanna M Karasinska, James T Topham, Steve E Kalloger, et al.
NPJ Precision Oncology|December 21, 2021
Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyuryLaura M Williamson, Craig M Rive, Daniela Di Francesco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2020
Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid TumorsAlexandra Pender, Emma Titmuss, Erin D Pleasance, et al.
Molecular Cancer Therapeutics|June 11, 2020
Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer TypesJames T Topham, Emma Titmuss, Erin D Pleasance, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic CancersErica S Tsang, Cameron J Grisdale, Erin Pleasance, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular CharacteristicsJames T Topham, Joanna M Karasinska, Michael K C Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?Erica S Tsang, James T Topham, Joanna M Karasinska, et al.
Pageof 3